Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenues	$ 602	$ 726
Cost of revenues	(31)	(22)
Gross profit	571	704
Sales and marketing expenses	61	205
General and administrative expenses	857	1,000
Research and development costs	212	334
Operating loss	(559)	(835)
Gain/(loss) from change in fair value of hybrid financial instruments	(299)	(31,170)
Gain/(loss) from change in fair value of derivative liability - warrants	3,122	(41,488)
Gain/(loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	6,774	(89,649)
Interest expense related to convertible debt	0	(2,392)
Net Income (loss) available to common shareholders	9,036	(165,534)
Comprehensive income (loss):
Net income (loss)	9,036	(165,534)
Other comprehensive gain/(loss) - investment in GmbH and foreign currency adjustment	(111)	(8)
Comprehensive income (loss)	$ 8,925	$ (165,542)
Net income (loss) per share, basic and diluted:
Basic (in dollars per share)	$ 0.003	$ (0.25)
Fully diluted (in dollars per share)	$ 0.003	$ (0.25)
Weighted average number of common shares:
Basic (in shares)	2,789,315,439	652,829,594
Fully diluted (in shares)	3,302,657,994	652,829,594